- Trials with a EudraCT protocol (3)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
3 result(s) found for: Atrioventricular node.
Displaying page 1 of 1.
| EudraCT Number: 2015-001129-17 | Sponsor Protocol Number: LDLL300.301 | Start Date*: 2017-06-19 | ||||||||||||||||||||||||||||||||||||
| Sponsor Name:AOP Orphan Pharmaceuticals GmbH | ||||||||||||||||||||||||||||||||||||||
| Full Title: A multicenter, open-label study to investigate the effectiveness and safety of AOP Landiolol in controlling supraventricular tachycardia in pediatric patients (LANDI-PED). | ||||||||||||||||||||||||||||||||||||||
| Medical condition: Supraventricular tachycardia in pediatric patients. | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
| Trial protocol: AT (Completed) DE (Ongoing) LT (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2005-001781-14 | Sponsor Protocol Number: POX-MVA-005 | Start Date*: 2006-04-11 | |||||||||||
| Sponsor Name:Bavarian Nordic A/S | |||||||||||||
| Full Title: A partially randomized, partially double-blind, placebo-controlled Phase II non-inferiority study to evaluate immunogenicity and safety of one and two doses of MVA-BN (IMVAMUNE™) smallpox vaccine i... | |||||||||||||
| Medical condition: Healthy subjects - prevention of smallpox infection | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-006297-28 | Sponsor Protocol Number: POX-MVA-023 | Start Date*: 2008-07-30 | |||||||||||
| Sponsor Name:Bavarian Nordic A/S | |||||||||||||
| Full Title: An open-label Phase II study to evaluate immunogenicity and safety of a single IMVAMUNE® booster vaccination two years after the last IMVAMUNE® vaccination in former POX-MVA-005 vaccinees | |||||||||||||
| Medical condition: Healthy subjects - prevention of smallpox infection | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.